http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#Head http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#assertion http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#provenance http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#pubinfo http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#assertion http://purl.obolibrary.org/obo/DOID_409 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_409 http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00819 http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association http://www.w3.org/2000/01/rdf-schema#label "Acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. It is contraindicated in patients with cirrhosis because of the risk of development of hepatic encephalopathy. Long-term administration of acetazolamide is contraindicated in patients with chronic non- congestive angle-closure glaucoma since it may permit organic closure of the angle to occur while the worsening glaucoma is masked by lowered intraocular pressure." http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00819 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#provenance http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#pubinfo http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#sig http://purl.org/nanopub/x/hasSignature c+Cw6foEctJxHd8S+FdtAalLH+JhG55sjdwa7UfqlBjAXlXVnEs0aLPWmkYN+k2Y+wEcdPPCcYIPGid3+7RCc3tJWxrpuR+oQR5qSLiwcB9gkpuTryl7GAt0hZtqe16X8wvRP6F+au2T1mNeRpep8fuHQSxRoiJy0UgT2YvVAI8= http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo http://purl.org/dc/terms/created 2021-08-25T13:50:42.610+02:00 http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA1vPuwZ5Td2fFVQvwAoCZ_Kpa479zoSmcSl7PLgzYxGo https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY